Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2015 Nov 18;22(3):514–519. doi: 10.1016/j.bbmt.2015.11.009

Table 1. Responses regarding the care of donors at the point of HLA typing, health care providers of donor care, and donor care policies in accredited and non-accredited EBMT transplant centers.

JACIE accredited Non-accredited P

Healthcare provider making initial contact prior to HLA-typing
Transplant physician 23 (40%) 24 (41%)
Other Physician 15 (26%) 17 (29)
Transplant Specialist Nurse 15 (26%) 14 (24%) 0.70
Other nurse 2(3%) 0
Non-clinical Admin 3 (5%) 3 (5%)

Information supplied to donors pre HLA typing
Verbal only 26 (4%) 34 (60%)
Local written information 31(53%) 20 (35%) 0.073
National written information 1(2%) 3(5%)

RD heath assessment pre-HLA typing
By written health questionnaire 12 (21%) 8 (14%)
Health questionnaire over phone 3 (5%) 1 (2%) 0.49
Verbal discussion open ended questions 18 (32%) 23 (40%)
No assessment 24 (42%) 25 (44%)

Willingness to donate is verified pre-HLA typing 40 (69%) 46 (79%) 0.20

Individual to whom donor HLA results are first disclosed
Donor 22 (38%) 9 (16%) 0.007
Recipient 10 (17%) 15 (26%)
Referring physician 23 (40%) 27 (47%)
No consistent practice 3 (5%) 6 (11%)

Background of the provider with ultimate responsibility for RD clearance
Internist/GP 1 (2%) 0
Non-transplant hematologist 29 (50%) 18 (31%) 0.036
Transplant physician 26 (45%) 40 (69%)
Other 2 (3%) 0

Role of the physician providing donor clearance in the recipient's care
Affiliated with transplant program with simultaneous responsibility for the recipient 8 (14%) 20 (35%)
Affiliated with the transplant program and may be involved in the care of the recipient 20 (34%) 17 (30%) 0.044
Affiliated with the transplant program but not involved in recipient's care 19 (33%) 15 (26%)
Not involved in the transplant program or the recipient's care 11 (19%) 5 (9%)

Existence of a written policy for RD care 58 (98%) 49 (83%) 0.004

Written eligibility criteria exist for acceptance of RDs 53 (93%) 45 (78%) 0.02

Source of eligibility criteria
Locally written 30 (53%) 21 (36%)
Based on NMDP criteria 16 (28%) 19 (33%)
Based on WMDA criteria 27 (48%) 12 (21%)

A health history questionnaire forms part of the assessment at donor medical 52 (91%) 41 (72%) 0.008

There is a policy defining the limit for the number of apheresis procedures RDs may undergo for their initial donation 39 (72%) 31 (55%) 0.057

Plerixa for has been used for mobilization of RDs
Yes 11 (20%) 21 (38%)
No 38 (69%) 34 (61%) 0.032
Only in the context of a clinical trial 6 (11%) 1 (2%)

BM harvests are performed by:
Transplant physicians caring for the recipient 43 (77%) 41 (87%)
Other transplant physicians or another team 13 (23%) 6(13%) 0.36

There is a process for credentialing physicians performing BM harvests 48 (86%) 29 (63%) 0.008

There is a policy defining the limit for the BM volume aspirated at harvest 37 (66%) 30 (65%) 0.984

Long term (10 year) follow up is performed 20 (34%) 8 (14%) 0.05